3 Results for "

C.albicans Infection model

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "C.albicans Infection model" in MCE Product Catalog:

Cat. No.: HY-134090
CAS No.: 51867-94-8
Synonyms: Antibiotic TS 885; NSC 248958
Target:  

Bacterial VSV

Research Areas:  

Infection

9-Methylstreptimidone is a microbial metabolite originally isolated from Streptomyces sp. S-885 that has antifungal and antiviral activities. It is active against several fungi, including S. sake, S. fragilis, R. rubra, T. rubra, and C. albidus (MICs=4-20 μg/mL) and has antiviral activity against poliovirus, vesicular stomatitis virus (VSV), and Newcastle disease virus (NDV) in vitro (MIC=0.02 μg/mL for all). 9-Methylstreptimidone increases survival in mouse models of infection with influenza A2 (H2N2) or C. albicans when administered prior to infection.
loading...
    loading...
Cat. No.: HY-139903
CAS No.: 2572713-30-3
Purity:  98.08%
Research Areas:  

Infection

Antifungal agent 18 is an antifungal agent. Antifungal agent 18 shows a broad-spectrum antifungal activity against major human fungal pathogens. Antifungal agent 18 compromises fungal cell wall integrity by targeting the unfolded protein response (UPR), calcineurin, and MAPK pathways. Antifungal agent 18 shows antifungal activity in virto and vivo. Antifungal agent 18 can be used for the research of invasive fungal pathogens and cutaneous dermatophytes .
loading...
    loading...
Cat. No.: HY-168998
CAS No.: 401816-26-0
Target:  

Fungal Casein Kinase

Research Areas:  

Infection

Yck2-IN-1 (Compound 2a) is an inhibitor of the fungal Candida albicans Yck2 kinase. It exhibits an IC50 of approximately 80 nM against Yck2 and a MIC80 of 12.5 µM against C. albicans, with good metabolic stability (66% remaining in mouse liver microsomes). In a mouse model of drug-resistant candidiasis, Yck2-IN-1 significantly reduced fungal burden in the kidneys. Yck2-IN-1 holds promise for research in the field of antifungal infection .
loading...
    loading...